TP53 and myelodysplastic syndrome: AZA, through its epigenetic mechanism, reactivates genes silenced by DNA methylation, thus enhancing the functional recovery of p53 mutant proteins by Eprenetapopt, and increasing the lethality of MDS cells (76–78) (Figure 1).